VC | pharmaphorum

Digital

Augmented intelligence: The next-gen engine for biopharma in...

Augmented intelligence is strategically valuable because it strengthens both the scientific and financial case for every decision.

Market Access

VCs upbeat about European life sciences market, despite unce...

It has been a curious start to the year for pharma and biotech investment.

R&D

Investing in the gleams of positivity and hope for life scie...

In this third instalment of the five-part, festive series of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Mark Andrews, investment director of life sciences funds at Brit

Augmented intelligence: The next-gen engine for biopharma in...

VCs upbeat about European life sciences market, despite unce...

Investing in the gleams of positivity and hope for life scie...

GSK pursues $10.6bn takeover of cancer biotech Nuvalent

Discover a new era of healthcare panel engagement: Grounded ...

VC

Editor's Picks